Stille AB (STIL) - Total Assets
Based on the latest financial reports, Stille AB (STIL) holds total assets worth Skr1.06 Billion SEK (≈ $113.54 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Stille AB shareholders equity for net asset value and shareholders' equity analysis.
Stille AB - Total Assets Trend (2008–2024)
This chart illustrates how Stille AB's total assets have evolved over time, based on quarterly financial data.
Stille AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Stille AB's total assets of Skr1.06 Billion consist of 41.3% current assets and 58.7% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 15.8% |
| Accounts Receivable | Skr104.82 Million | 10.5% |
| Inventory | Skr144.68 Million | 14.5% |
| Property, Plant & Equipment | Skr71.77 Million | 7.2% |
| Intangible Assets | Skr367.17 Million | 36.7% |
| Goodwill | Skr136.78 Million | 13.7% |
Asset Composition Trend (2008–2024)
This chart illustrates how Stille AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Stille AB market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Stille AB's current assets represent 41.3% of total assets in 2024, a decrease from 69.9% in 2008.
- Cash Position: Cash and equivalents constituted 15.8% of total assets in 2024, up from 15.1% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 26.0% in 2008.
- Asset Diversification: The largest asset category is intangible assets at 36.7% of total assets.
Stille AB Competitors by Total Assets
Key competitors of Stille AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Stille AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.24 | 2.07 | 3.67 |
| Quick Ratio | 1.87 | 1.12 | 2.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr274.20 Million | Skr193.68 Million | Skr74.17 Million |
Stille AB - Advanced Valuation Insights
This section examines the relationship between Stille AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.40 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 24.4% |
| Total Assets | Skr1.00 Billion |
| Market Capitalization | $229.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values Stille AB's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Stille AB's assets grew by 24.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Stille AB (2008–2024)
The table below shows the annual total assets of Stille AB from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr1.00 Billion ≈ $107.74 Million |
+24.38% |
| 2023-12-31 | Skr804.89 Million ≈ $86.62 Million |
+134.97% |
| 2022-12-31 | Skr342.55 Million ≈ $36.86 Million |
+10.91% |
| 2021-12-31 | Skr308.85 Million ≈ $33.24 Million |
+87.30% |
| 2020-12-31 | Skr164.90 Million ≈ $17.75 Million |
+1.50% |
| 2019-12-31 | Skr162.46 Million ≈ $17.48 Million |
+40.89% |
| 2018-12-31 | Skr115.30 Million ≈ $12.41 Million |
+24.86% |
| 2017-12-31 | Skr92.34 Million ≈ $9.94 Million |
+14.82% |
| 2016-12-31 | Skr80.42 Million ≈ $8.65 Million |
+15.70% |
| 2015-12-31 | Skr69.51 Million ≈ $7.48 Million |
+24.81% |
| 2014-12-31 | Skr55.69 Million ≈ $5.99 Million |
-10.67% |
| 2013-12-31 | Skr62.34 Million ≈ $6.71 Million |
-7.08% |
| 2012-12-31 | Skr67.09 Million ≈ $7.22 Million |
+3.65% |
| 2011-12-31 | Skr64.72 Million ≈ $6.97 Million |
+12.95% |
| 2010-12-31 | Skr57.30 Million ≈ $6.17 Million |
-7.35% |
| 2009-12-31 | Skr61.85 Million ≈ $6.66 Million |
+4.43% |
| 2008-12-31 | Skr59.23 Million ≈ $6.37 Million |
-- |
About Stille AB
Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascu… Read more